IMARC Group’s report titled “Veterinary Vaccines Market Report by Vaccine Type (Livestock Vaccines, Companion Animal Vaccines), Technology (Attenuated Live Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, and Others), Route of Administration (Subcutaneous, Intramuscular, Intranasal), Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores, and Others), and Region 2025-2033”. The global veterinary vaccines market size reached USD 14.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 29.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.71% during 2025-2033.
Factors Affecting the Growth of Veterinary Vaccines Industry:
- Increasing Pet Ownership and Companion Animal Population:
The market for veterinary vaccines is on the rise due to increasing pet adoption across the global. Globally, an increasing number of people accept having pets in their homes, and the need for preventive health care measures has increased, including vaccination. This trend is in fact more keenly felt in Regions like North America and Europe where people own pets in large numbers. Furthermore, those regions of the world that have developed as new economies like China and India have a growing per capita disposable income that the pet owners are spending on pet’s health care. The increasing number of pet animals also contribute to the increased rate in usage of veterinary vaccines. More pets within homes mean that more animal within the homes can be affected by infectious disease. It is impossible to overemphasize the importance of the veterinary vaccines for the variety of the infectious diseases like rabies, canine distemper, feline leukemia, and parvovirus, and to protect the health of pets. Furthermore, an increased general knowledge about the need to get pets vaccinated to prevent diseases that are preventable has promoted veterinary vaccines among the pet owners.
- Significant Technological Advancements and Product Innovations:
Technology and novelties about products, both serve a significant position in the development of the veterinary vaccines market. The science of veterinary medicine has undergone considerable developments in last decade due to enhancement in technologies like biotechnology, genomics Immunology. These technological advancements have brought overwhelming impacts on the development and manufacturing of the vaccines, the kinds of vaccines produced are safer, effective and genetically engineered vaccines. Another major breakthrough under the category of vaccines is the recombinant DNA vaccines. These vaccines are intended to introduce genetic material of pathogens into host cells and then maintain immunity by producing specific antigenic responses. The recombinant DNA vaccine provokes numerous above and beyond advantages over the previous approaches touching on safety, immunogenicity, more extensive and persistent immune reactions.
- Increasing Incidence of Zoonotic Diseases:
The rising incidence of zoonotic diseases is a key driver fueling the growth of the veterinary vaccines market. Zoonotic diseases are infectious diseases that can spread between animals and humans, posing significant public health threats. With increasing urbanization, land use changes, and greater proximity between humans and animals, the risk of zoonotic disease transmission has increased globally. A notable example of a zoonotic disease is rabies, a fatal viral infection that affects both animals and humans. Rabies is primarily transmitted through the bite of an infected animal, such as a dog, bat, or wildlife. Vaccination plays a key role in the prevention of rabies, with large-scale vaccination campaigns targeting domestic and wild animal populations being helpful in controlling the spread of the disease. The demand for veterinary rabies vaccines is particularly high in regions where rabies is endemic, which fuels the market growth.
Grab a sample PDF of this report: https://www.imarcgroup.com/veterinary-vaccines-market/requestsample
Leading Companies Operating in the Global Veterinary Vaccines Industry:
- Boehringer Ingelheim International GmbH
- Ceva Santé Animale
- Elanco Animal Health Incorporated
- Hester Biosciences Limited
- HIPRA, Indian Immunologicals Limited
- Merck & Co. Inc.
- Neogen Corporation
- Phibro Animal Health Corporation
- Virbac SA and Zoetis Inc.
Veterinary Vaccines Market Report Segmentation:
By Vaccine Type:
- Livestock Vaccines
- Bovine Vaccines
- Poultry Vaccines
- Porcine Vaccines
- Others
- Companion Animal Vaccines
- Canine Vaccines
- Feline Vaccines
- Equine Vaccines
Livestock vaccines hold maximum number of shares due to the extensive global demand for vaccines to prevent infectious diseases in livestock populations, which are vital for ensuring food security and sustaining agricultural productivity.
By Technology:
- Attenuated Live Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Others
Attenuated live vaccines dominate the market due to their ability to closely mimic natural infections, eliciting robust and long-lasting immune responses against a broad spectrum of pathogens in both veterinary and human medicine.
By Route of Administration:
- Subcutaneous
- Intramuscular
- Intranasal
Subcutaneous represents the largest segment due to its ease of administration, high patient acceptance, and ability to provide sustained release of vaccine antigens.
By Distribution Channel:
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies and Drug Stores
- Others
Veterinary clinics dominate the market due to their role as primary points of contact for pet owners seeking comprehensive veterinary care, including vaccination services, for their animals.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America’s dominance in the veterinary vaccines market is attributed to factors such as high pet ownership rates, stringent regulatory standards, advanced healthcare infrastructure, and robust research and development activities in the veterinary vaccines sector.
Global Veterinary Vaccines Market Trends:
Government initiatives and policies aimed at promoting animal health and welfare play a key role in driving the veterinary vaccines market. Many governments around the world implement vaccination programs by targeting livestock populations to control and prevent the spread of infectious diseases, enhance food security, and support agricultural productivity. These programs often include subsidies or incentives to encourage farmers and livestock producers to vaccinate their animals regularly, thereby increasing the demand for veterinary vaccines. Additionally, stringent regulations mandating the vaccination of certain animals such as pets, working animals, and livestock further drive market growth by ensuring compliance with preventive healthcare measures. Government-funded research grants and collaborations with pharmaceutical companies also promote innovation in vaccine development, leading to the introduction of new and improved veterinary vaccines to address emerging disease threats and public health concerns.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145